How much funding has BioAge Labs raised?

BioAge Labs has raised $170.0M in total funding, most recently a Series D round.

Who are BioAge Labs's investors?

BioAge Labs's investors include Sofinnova Investments, Andreessen Horowitz.

When was BioAge Labs founded?

BioAge Labs was founded in 2015.

Where is BioAge Labs headquartered?

BioAge Labs is headquartered in San Francisco Bay Area, California, United States.

What industry is BioAge Labs in?

BioAge Labs operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does BioAge Labs have?

BioAge Labs has 51-200 employees.

BioAge Labs

IPO

Harnessing aging to transform health

Public · San Francisco Bay Area, United States · Founded 2015 · $170.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: San Francisco Bay Area, California
Employees: 51–200
Founded: 2015
Business Model: Other
Website: bioagelabs.com

Total Funding: $170.0M
Last Round: $170.0M Series DFeb 2024
Rounds: 1
Type: Public

About

BioAge Labs harnesses the biology of human aging to develop therapies for metabolic diseases like obesity and cardiovascular issues. Their pipeline features BGE-102, an NLRP3 inhibitor for inflammation, and an APJ agonist mimicking exercise effects, discovered via a human-first multi-omics platform.

Summary

BioAge Labs is an Artificial Intelligence company based in San Francisco Bay Area, United States, founded in 2015. It has raised $170.0M in total across 1 round, most recently a $170.0M Series D round in Feb 2024. Investors include Sofinnova Investments and Andreessen Horowitz.

LinkedIn X (Twitter)